Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H18N2O4S.C13H20N2O2.H2O |
Molecular Weight | 588.716 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.[H][C@]23SC(C)(C)[C@@H](N2C(=O)[C@H]3NC(=O)CC4=CC=CC=C4)C(O)=O
InChI
InChIKey=KZDCMKVLEYCGQX-UDPGNSCCSA-N
InChI=1S/C16H18N2O4S.C13H20N2O2.H2O/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9;1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11;/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);5-8H,3-4,9-10,14H2,1-2H3;1H2/t11-,12+,14-;;/m1../s1
Molecular Formula | C16H18N2O4S |
Molecular Weight | 334.39 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C13H20N2O2 |
Molecular Weight | 236.3101 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:16:27 UTC 2023
by
admin
on
Fri Dec 15 16:16:27 UTC 2023
|
Record UNII |
17R794ESYN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1500
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 526.1696B
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
WHO-VATC |
QG51AG01
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 526.1696C
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
WHO-ATC |
J01CE09
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 558.145
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 526.1696A
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.1
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 522.1696
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
WHO-VATC |
QJ51RC04
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 522.1696A
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
WHO-VATC |
QJ01CE09
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 522.1696C
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 526.1696D
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 558.145
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
WHO-VATC |
QJ51CE09
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
WHO-VATC |
QJ51CE59
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
CFR |
21 CFR 522.1696B
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
||
|
WHO-VATC |
QJ51RC23
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6130-64-9
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
PROCAINE BENZYLPENICILLIN
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
52154
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
1502552
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
DB09320
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
Procaine Penicillin G
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
7983
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID40210207
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
SUB22648
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
ALTERNATIVE | |||
|
D010402
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
m8476
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | Merck Index | ||
|
17R794ESYN
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
SUB00752MIG
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
PENICILLIN G PROCAINE
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder; odourless or almost odourless. Solubility: Slightly soluble in water; soluble in ethanol (~750 g/l) TS. Category: Antibacterial drug. Storage: Procaine benzylpenicillin should be kept in a tightly closed container and protected from light. Labelling: The designation sterile Procaine benzylpenicillin indicates that the substance complies with the additional requirementsfor sterile Procaine benzylpenicillin and may be used for parenteral administration or for other sterile applications. Additional information: Solutions of Procaine benzylpenicillin are dextrorotatory. It is readily decomposed by acids, alkalis, andoxidizing agents. Even in the absence of light, it is gradually degraded on exposure to a humid atmosphere, the decompositionbeing faster at higher temperatures. | ||
|
CHEMBL1628385
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
17R794ESYN
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
100000088581
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
4459
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
C87370
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY | |||
|
22502
Created by
admin on Fri Dec 15 16:16:27 UTC 2023 , Edited by admin on Fri Dec 15 16:16:27 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE | |||
|
ANHYDROUS->SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY | |||
|
ACTIVE MOIETY |